Morton Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
9,722
+275
| +3% | +$51K | 0.32% | 29 |
|
|
2025
Q1 | $1.98M | Buy |
9,447
+92
| +1% | +$19.3K | 0.38% | 24 |
|
|
2024
Q4 | $1.66M | Buy |
9,355
+168
| +2% | +$29.9K | 0.31% | 27 |
|
|
2024
Q3 | $1.81M | Buy |
9,187
+358
| +4% | +$70.7K | 0.36% | 24 |
|
|
2024
Q2 | $1.51M | Sell |
8,829
-556
| -6% | -$95.4K | 0.36% | 26 |
|
|
2024
Q1 | $1.71M | Sell |
9,385
-263
| -3% | -$47.9K | 0.46% | 22 |
|
|
2023
Q4 | $1.5M | Buy |
9,648
+186
| +2% | +$28.8K | 0.44% | 22 |
|
|
2023
Q3 | $1.41M | Buy |
9,462
+64
| +0.7% | +$9.54K | 0.5% | 19 |
|
|
2023
Q2 | $1.27M | Buy |
9,398
+34
| +0.4% | +$4.58K | 0.43% | 22 |
|
|
2023
Q1 | $1.49M | Sell |
9,364
-563
| -6% | -$89.7K | 0.53% | 18 |
|
|
2022
Q4 | $1.6M | Buy |
9,927
+5
| +0.1% | +$808 | 0.63% | 16 |
|
|
2022
Q3 | $1.33M | Buy |
9,922
+558
| +6% | +$74.9K | 0.61% | 16 |
|
|
2022
Q2 | $1.43M | Buy |
9,364
+619
| +7% | +$94.8K | 0.62% | 16 |
|
|
2022
Q1 | $1.42M | Buy |
8,745
+9
| +0.1% | +$1.46K | 0.58% | 16 |
|
|
2021
Q4 | $1.18M | Buy |
+8,736
| New | +$1.18M | 0.48% | 21 |
|